Regulation of MAP kinases by docking domains

Biology of the Cell

Volumn 93, Issue 1-2, 2001, Pages 5-14

  Enslen, Hervé ^a   Davis, Roger J ^b  

^a INSTITUT DU FER À MOULIN   (France)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Docking; MAP kinase; Phosphatase; Scaffold

Indexed keywords

DOCKING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHOPROTEIN PHOSPHATASE; SYNAPTOPHYSIN;

CONTROLLED STUDY; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY MECHANISM; REVIEW;

EID: 0034759115     PISSN: 02484900     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-4900(01)01156-X     Document Type: Review

References (111)

1. Two co-existing mechanisms for nuclear import of MAP kinase: Passive diffusion of a monomer and active transport of a dimer
2. Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism
3. Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines
4. Growth regulation via p38 mitogen-activated protein kinase in developing liver
5. A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission
6. Signaling in the yeast pheromone response pathway: Specific and high- affinity interaction of the mitogen-activated protein (MAP) kinases Kss1 and Fus3 with the upstream MAP kinase kinase Ste7
7. A conserved motif at the amino termini of MEKs might mediate high- affinity interaction with the cognate MAPKs
8. SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia
9. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2
10. A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase
11. The sevenmaker gain-of-function mutation in p42 MAP kinase leads to enhanced signaling and reduced sensitivity to dual specificity phosphatase action
12. Identification of MAP kinase domains by redirecting stress signals into growth factor responses
13. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry
14. A gain-of-function mutation in Drosophila MAP kinase activates multiple receptor tyrosine kinase signaling pathways
15. Dual specificity phosphatases: A gene family for control of MAP kinase function
16. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase
17. Mammalian MAP kinase signaling cascades
18. Discordance between the Binding Affinity of Mitogen-activated Protein Kinase Subfamily Members for MAP Kinase Phosphatase-2 and Their Ability to Activate the Phosphatase Catalytically
19. Nuclear localization and regulation of ERK- and Rsk-encoded protein kinases
20. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP- 2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation
21. MAP kinase pathways
22. Dimerization in MAP-kinase signaling
23. The search for physiological substrates of MAP and SAP kinases in mammalian cells
24. The development and therapeutic potential of protein kinase inhibitors
25. Selective activation of p38α and p38γ by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells
26. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis
27. The Ste20 group kinases as regulators of MAP kinase cascades
28. MAPKs: New JNK expands the group
29. Signal transduction by the JNK group of MAP kinases
30. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms
31. Signaling by dual specificity kinases
32. Activation of the p38 mitogen-activated protein kinase pathway arrests cell cycle progression and differentiation of immature thymocytes in vivo
33. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways
34. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor
35. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2
36. Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation
37. Molecular determinants that mediate selective activation of p38 MAP kinase isoforms
38. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6
39. A novel regulatory mechanism in the mitogen-activated protein (MAP) kinase cascade. Role of nuclear export signal of MAP kinase kinase
40. Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal
41. Interaction of MAP kinase with MAP kinase kinase: Its possible role in the control of nucleocytoplasmic transport of MAP kinase
42. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases
43. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus
44. Characterization of the structure and function of a novel MAP kinase kinase (MKK6)
45. Selective suppression of stress-activated protein kinase pathway by protein phosphatase 2C in mammalian cells
46. Regulation of the TAK1 signaling pathway by protein phosphatase 2C
47. Signaling- 2000 and beyond
48. Two protein-tyrosine phosphatases inactivate the osmotic stress response pathway in yeast by targeting the mitogen-activated protein kinase, Hog1
49. Structure-function studies of p38 mitogen-activated protein kinase. Loop 12 influences substrate specificity and autophosphorylation, but not upstream kinase selection
50. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C
51. Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3
52. Protein phosphatases and the regulation of MAP kinase activity
53. Meaningful relationships: The regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
54. SKK4, a novel activator of stress-activated protein kinase-1 (SAPK1/JNK)
55. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts
56. Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
57. Activation of yeast PBS2 MAPKK by MAPKKKs or by binding of an SH3- containing osmosensor
58. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38γ) MAP kinase pathway
59. MKP7, a novel MAP kinase phosphatase, functions as a shuttle protein
60. β-arrestin 2: A receptor-regulated MAPK scaffold for the activation of JNK3
61. Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8(+) but not CD4(+) T cells
62. Pyp1 and Pyp2 PTPases dephosphorylate an osmosensing MAP kinase controlling cell size at division in fission yeast
63. Identification of a motif in the carboxyl terminus of β-arrestin2 responsible for activation of JNK3
64. Purification and identification of a major activator for p38 from osmotically shocked cells. Activation of mitogen-activated protein kinase kinase 6 by osmotic shock, tumor necrosis factor-α, and H2O2
65. The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity
66. p38 MAP kinases: Beyond the stress response
67. Induction of apoptosis by SB202190 through inhibition of p38β mitogen-activated protein kinase
68. Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3
69. Protein-protein interactions define specificity in signal transduction
70. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
71. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ-induced release of NO and TNFα
72. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif
73. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells
74. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen- activated protein kinase signal transduction pathway
75. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway
76. Contributions of the mitogen-activated protein (MAP) kinase backbone and phosphorylation loop to MEK specificity
77. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation
78. Identification of a cytoplasmic-retention sequence in ERK2
79. Negative regulation of T cell antigen receptor signal transduction by hematopoietic tyrosine phosphatase (HePTP)
80. MP1: A MEK binding partner that enhances enzymatic activation of the MAP kinase cascade
81. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
82. Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells
83. Docking domains and substrate-specificity determination for MAP kinases
84. Distinct binding determinants for ERK2/p38α and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1
85. The MAPK kinase Pek1 acts as a phosphorylation-dependent molecular switch
86. Protein phosphatase 2Cα inhibits the human stress-responsive p38 and JNK MAPK pathways
87. A conserved docking motif in MAP kinases common to substrates, activators and regulators
88. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions
89. A Novel MAPK Phosphatase MKP-7 Acts Preferentially on JNK/SAPK and p38α and β MAPKs
90. MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases
91. Nuclear localization of mitogen-activated protein kinase kinase 1 (MKK1) is promoted by serum stimulation and G2-M progression. Requirement for phosphorylation at the activation lip and signaling downstream of MKK
92. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines
93. The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases
94. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor
95. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family
96. Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells
97. A mammalian scaffold complex that selectively mediates MAP kinase activation
98. Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals
99. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human
100. The mitogen-activated protein kinase p38-2 is necessary for the inhibition of N-type calcium current by bradykinin
101. Phosphorylation of MAP kinases by MAP/ERK involves multiple regions of MAP kinases
102. Regulation of the Saccharomyces cerevisiae HOG1 mitogen-activated protein kinase by the PTP2 and PTP3 protein tyrosine phosphatases
103. JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension
104. Hydrophobic as well as charged residues in both Mek1 and Erk2 are important for their proper docking
105. The N-terminal ERK-binding site of MEK1 is required for efficient feedback phosphorylation by ERK2 in vitro and ERK activation in vivo
106. Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade
107. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity
108. The JIP group of mitogen-activated protein kinase scaffold proteins
109. Altered regulation of ERK1b by MEK1 and PTP-SL, and modified Elk1-phosphorylation by ERK1b are caused by abrogation of the regulatory C- terminal sequence of ERKs
110. ERK1b a 46-kDa ERK isoform that is differentially regulated by MEK
111. Multiple regions of MAP kinase phosphatase 3 are involved in its recognition and activation by ERK2